---
title: 'Re: [<sup>177</sup>Lu]Lu-PSMA-617 plus Enzalutamide in Patients with Metastatic
  Castration-resistant Prostate Cancer (ENZA-p): An Open-label, Multicentre, Randomised,
  Phase 2 Trial'
date: '2024-07-20'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39033070/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240721181857&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: No ...
disable_comments: true
---
No ...